Patents by Inventor Kevin V. Martin

Kevin V. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170088865
    Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA).
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
  • Patent number: 9528133
    Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: December 27, 2016
    Assignee: Synthetic Genomics, Inc.
    Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
  • Patent number: 9506090
    Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: November 29, 2016
    Assignee: Synthetic Genomics, Inc.
    Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
  • Patent number: 9080188
    Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce methylbutanol and other compounds of interest from renewable feedstocks.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: July 14, 2015
    Assignee: Synthetic Genomics, Inc.
    Inventors: Stephen Picataggio, Robert C. Brown, Jessica R. Kristof, Gena Roy, Prachee Prakash, Stuart A. Underwood, Kevin Watts, Kevin V. Martin
  • Publication number: 20140322780
    Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce methylbutanol and other compounds of interest from renewable feedstocks.
    Type: Application
    Filed: November 28, 2011
    Publication date: October 30, 2014
    Inventors: Stephen Picataggio, Robert C. Brown, Jessica R. Kristof, Gena Roy, Prachee Prakash, Stuart A. Underwood, Kevin Watts, Kevin V. Martin
  • Publication number: 20140206047
    Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.
    Type: Application
    Filed: March 21, 2014
    Publication date: July 24, 2014
    Applicant: Synthetic Genomics, Inc.
    Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
  • Publication number: 20140106414
    Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.
    Type: Application
    Filed: September 20, 2013
    Publication date: April 17, 2014
    Applicant: SYNTHETIC GENOMICS, INC.
    Inventors: Spiros KAMBOURAKIS, Kevin V. MARTIN
  • Patent number: 8309323
    Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce 2,6-dimethyloctane as an advanced biofuel from renewable feedstocks.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: November 13, 2012
    Assignee: Synthetic Genomics, Inc.
    Inventors: Kevin V. Martin, Stephen Picataggio, Paul Roessler, John Verruto, Kevin Watts
  • Patent number: 8114641
    Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce methyl butanol and other compounds of interest from renewable feedstocks.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: February 14, 2012
    Assignee: Synthetic Genomics, Inc.
    Inventors: Stephen Picataggio, Robert C. Brown, Jessica R. Kristof, Gena Roy, Prachee Prakash, Stuart A. Underwood, Kevin Watts, Kevin V. Martin
  • Publication number: 20110160501
    Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce 2,6-dimethyloctane as an advanced biofuel from renewable feedstocks.
    Type: Application
    Filed: November 13, 2008
    Publication date: June 30, 2011
    Inventors: Kevin V. Martin, Stephen Picataggio, Paul Roessler, John Verruto, Kevin Watts
  • Patent number: 7582758
    Abstract: Methods for the synthesis of cyclic phosphonic acid diesters from 1,3-diols are described, whereby cyclic phosphonic acid diesters are produced by reacting a chiral 1,3-diol and an activated phosphonic acid in the presence of a Lewis acid.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: September 1, 2009
    Assignee: Metabasis Therapeutics, Inc.
    Inventor: Kevin V. Martin
  • Patent number: 6107523
    Abstract: Novel modified and improved beta-diketones and their use in the extraction of copper from aqueous ammoniacal solutions containing copper values, resulting from commercial processes, including, but not limited to, leaching of copper containing ores, such as sulfidic ores, or concentrates resulting from flotation of such sulfidic ores. The novel diketones are those highly sterically hindered, which may be represented by the formula I or II: ##STR1## The preferred beta-diketones of Formula [II] are selected from the group consisting of neo-alkyl beta-diketones, such as, 1-phenyl-3-neoalkyl-1,3 propanedione in which the neoalkyl group is selected from neohexyl, neoheptyl, neooctyl, neononyl, or neodecyl.
    Type: Grant
    Filed: December 17, 1997
    Date of Patent: August 22, 2000
    Assignee: Henkel Corporation
    Inventors: Michael J. Virnig, Gary A. Kordosky, Sang I. Kang, Kevin V. Martin, Phillip L. Mattison
  • Patent number: 5936129
    Abstract: A process for making a sterically-hindered beta-diketone involving: (a) providing a solution comprising: (i) an ester; (ii) a base; and (iii) a solvent; (b) adding a ketone selected from the group consisting of an aromatic ketone and a hindered aliphatic ketone, to the solution, to form a condensation reaction mixture, whereby either the ester or the ketone is hindered; (c) reacting the solution with the ketone to form a sterically-hindered beta-diketone; and (d) recovering the sterically-hindered beta-diketone from the condensation reaction mixture.
    Type: Grant
    Filed: January 22, 1998
    Date of Patent: August 10, 1999
    Assignee: Henkel Corporation
    Inventors: Kevin V. Martin, Phillip L. Mattison, Michael J. Virnig